Jinpeng Sun
Union Hospital
Wuhan, 430022, China
Wuhan, 430022, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Potential Biomarker and Therapeutic Tools for Pathological Cardiac Hypertrophy and Heart Failure: Extracellular Vesicles.
Journal: International journal of molecular sciences
Published: November 18, 2025
Intelligent responsive PVA hydrogel loaded with composite MXene nanozyme enables efficient myocardial infarction repair by disrupting the oxidative stress-inflammation cascade.
Journal: Materials today. Bio
Published: September 08, 2025
How Advanced is Nanomedicine to Treat Atherosclerosis? A Comprehensive Review of the Literature.
Journal: International journal of nanomedicine
Published: August 27, 2025
Nitric Oxide in Biomaterial-Based Therapies for Coronary Heart Disease: Mechanistic Insights, Current Advances, and Translational Prospects.
Journal: Biomaterials research
Published: July 05, 2025
Bioinformatics Approach to Investigating the Immuno-Inflammatory Mechanisms of Periodontitis in the Progression of Atherosclerosis.
Journal: Current issues in molecular biology
Published: February 16, 2025
Lung-Derived Small Extracellular Vesicles Containing miR-15a-5p/miR-96-5p Promote Myocardial Fibrosis in Hypertrophic Cardiomyopathy via Targeting SMAD7.
Journal: Small (Weinheim an der Bergstrasse, Germany)
Published: February 07, 2025
Targeted Anti-Inflammatory Nanozymes with Pro-Angiogenic Activity for Myocardial Infarction Therapy.
Targeted Anti-Inflammatory Nanozymes with Pro-Angiogenic Activity for Myocardial Infarction Therapy.
Journal: Advanced healthcare materials
Published: December 11, 2024
Cartilage oligomeric matrix protein is an endogenous β-arrestin-2-selective allosteric modulator of AT1 receptor counteracting vascular injury.
Journal: Cell research
Published: August 19, 2020
Showing 1-8 of 8
Last Updated: 09/26/2026